Trademark Overview
On Tuesday, May 23, 2023, a trademark application was filed for BIOLINERX with the United States Patent and Trademark Office. The USPTO has given the BIOLINERX trademark a serial number of 76760226. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 19, 2026. This trademark is owned by BioLineRx Ltd.. The BIOLINERX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical product development services, namely, pharmaceutical product development through the discovery of compounds that helps for the treatment of a variety of diseases and symptoms; pharmaceutical product development services for a wide variety of diseases and symptoms, namely, neuropathic pain, acute kidney injury, inflammatory bowel disease, adult diabetes, weight loss among cancer patients, bacterial infections, rheumatoid arthritis, celiac disease, psoriasis, solid cancerous tumors, myocardial infarction, schizophrenia and prostate cancer; pharmaceutical product development services of new compounds for use in medicines for oncology patients; pharmaceutical research services; research and development services in the field of biotechnology
